— Know what they know.
Not Investment Advice
Also trades as: 2616.HK (HKSE) · $vol 8M

CSPHF OTC

CStone Pharmaceuticals
1W: +4.9% 1M: +10.4% 3M: +26.9% YTD: -15.4% 1Y: -24.5% 3Y: +51.0% 5Y: -32.0%
$0.76
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 52 · $1.2B mcap · 1.24B float · 0.0003% daily turnover · Short 71% of daily vol

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

D+
Oct 02, 2026
DCF
1
ROE
1
ROA
1
D/E
1
P/E
1
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. CSPHF receives an overall rating of D+. Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (2/5).
Rating Change History
DateFromTo
2026-10-02 C- D+
2026-08-29 D+ C-
2026-07-01 None ADDED
2026-06-17 EXISTED None
2026-06-12 None ADDED
2026-06-06 EXISTED None
2026-06-01 None ADDED
2026-04-01 EXISTED None
2026-03-25 None ADDED
2026-02-28 EXISTED None

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade D
Profitability
13
Balance Sheet
13
Earnings Quality
49
Growth
48
Value
—
Momentum
50
Safety
—
Cash Flow
30

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
—
—
Piotroski F-Score
4/9
✗ ✗ ✓ ✓ ✓ ✓ ✗ ✗ ✗
Beneish M-Score
-3.05
Unlikely Manipulator
Ohlson O-Score
-6.49
Bankruptcy prob: 0.2%
Low Risk
Credit Rating
BBB-
Score: 50.0/100
Trend: Improving
Earnings Quality
—
OCF/NI: 0.79x
Accruals: -7.6%
The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. CSPHF scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. CSPHF's score of -3.05 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. CSPHF's implied 0.2% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. CSPHF receives an estimated rating of BBB- (score: 50.0/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-17.90x
PEG
0.44x
P/S
18.29x
P/B
5.69x
P/FCF
—
P/OCF
—
EV/EBITDA
—
EV/Revenue
—
EV/EBIT
—
EV/FCF
—
Earnings Yield
—
FCF Yield
—
Shareholder Yield
—
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. CSPHF currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.020
NI / EBT
×
Interest Burden
1.046
EBT / EBIT
×
EBIT Margin
-1.029
EBIT / Rev
×
Asset Turnover
0.333
Rev / Assets
×
Equity Multiplier
2.039
Assets / Equity
=
ROE
-74.4%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. CSPHF's ROE of -74.4% is driven by Asset Turnover (0.333), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.02 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1318 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$0.76
Median 1Y
$0.13
5th Pctile
$0.01
95th Pctile
$2.78
Ann. Volatility
184.0%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
ROE -18.6% -56.7% -2.0% -3.0% -1.7% -1.5% -1.5% -1.3% -1.1% -83.7% -72.7% -74.4% -74.41%
ROA -14.6% -45.8% -1.1% -1.4% -1.0% -99.2% -64.6% -50.3% -30.2% -27.0% -25.8% -36.5% -36.50%
ROIC 79.7% 32.6% 5.0% 235.6% 7.1% 8.6% 5.3% 16.3% -12.0% -8.8% -6.7% -5.5% -5.53%
ROCE -11.8% -45.8% -1.6% -2.3% -4.0% -2.6% -1.9% -1.4% -98.5% -1.0% -45.3% -39.5% -39.55%
Gross Margin 76.8% 60.7% 54.0% 64.6% 49.8% 58.7% 74.5% 67.7% 44.5% -1.9% 64.2% 44.7% 44.68%
Operating Margin -34.5% -9.5% -6.6% -1.4% -2.4% -97.1% -1.7% -1.4% -66.9% -5.6% -70.6% -1.1% -1.15%
Net Margin -52.9% -9.7% -7.0% -1.4% -2.5% -80.0% -78.1% 6.2% -69.9% -5.5% -75.8% -1.2% -1.23%
EBITDA Margin -34.2% -9.4% -6.5% -1.4% -2.4% -93.4% -1.7% 1.3% -55.7% -5.4% -60.7% -1.0% -1.04%
FCF Margin 8.1% -70.5% -1.2% -1.3% -3.0% -1.8% -1.3% -1.0% -1.1% -1.1% -74.8% -87.1% -87.10%
OCF Margin 12.8% -64.6% -1.1% -1.2% -2.9% -1.7% -1.3% -1.0% -1.1% -1.1% -74.8% -87.0% -87.04%
ROE 3Y Avg snapshot only -1.80%
ROA 3Y Avg snapshot only -76.88%
ROIC Economic snapshot only -30.22%
Cash ROA snapshot only -25.26%
Cash ROIC snapshot only -5.80%
CROIC snapshot only -5.81%
NOPAT Margin snapshot only -82.96%
Pretax Margin snapshot only -1.08%
R&D / Revenue snapshot only 88.28%
SGA / Revenue snapshot only 58.83%
SBC / Revenue snapshot only 0.94%
Valuation
Metric Trend Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
P/E Ratio — — — — — — — — — — — — -17.895
P/S Ratio — — — — — — — — — — — — 18.287
P/B Ratio — — — — — — — — — — — — 5.688
P/FCF — — — — — — — — — — — — —
P/OCF — — — — — — — — — — — — —
EV/EBITDA — — — — — — — — — — — — —
EV/Revenue — — — — — — — — — — — — —
EV/EBIT — — — — — — — — — — — — —
EV/FCF — — — — — — — — — — — — —
Earnings Yield — — — — — — — — — — — — —
FCF Yield — — — — — — — — — — — — —
PEG Ratio snapshot only 0.442
Leverage & Solvency
Metric Trend Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
Current Ratio 4.91 5.69 2.10 1.75 1.32 1.54 1.56 1.71 1.60 1.44 2.18 3.58 3.582
Quick Ratio 4.91 5.63 2.03 1.69 1.29 1.51 1.44 1.45 1.18 1.20 1.95 3.44 3.435
Debt/Equity 0.03 0.04 0.14 0.25 0.64 0.36 0.80 0.72 0.98 1.24 0.57 0.28 0.276
Net Debt/Equity -1.12 -1.01 -1.29 -1.01 -1.68 -1.34 -1.50 -1.12 -0.87 -0.83 -0.92 -0.93 -0.931
Debt/Assets 0.02 0.03 0.08 0.12 0.17 0.13 0.22 0.22 0.26 0.33 0.26 0.17 0.174
Debt/EBITDA -0.24 -0.09 -0.08 -0.09 -0.11 -0.10 -0.25 -0.30 -0.53 -0.70 -1.01 -0.64 -0.637
Net Debt/EBITDA 9.32 2.14 0.71 0.38 0.28 0.37 0.46 0.47 0.47 0.47 1.65 2.15 2.147
Interest Coverage — — — — -440.95 -174.44 -118.01 -88.85 -85.13 -129.63 -35.75 -38.80 -38.798
Equity Multiplier 1.27 1.24 1.88 2.12 3.65 2.75 3.64 3.28 3.83 3.78 2.20 1.59 1.591
Cash Ratio snapshot only 3.092
Debt Service Coverage snapshot only -35.436
Cash to Debt snapshot only 4.368
FCF to Debt snapshot only -1.454
Defensive Interval snapshot only 693.6 days
Efficiency & Turnover
Metric Trend Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
Asset Turnover 0.28 0.39 0.56 0.77 0.27 0.40 0.48 0.53 0.57 0.44 0.43 0.33 0.333
Inventory Turnover — 9.04 5.68 8.18 27.93 15.55 4.26 2.99 2.12 3.44 2.80 2.70 2.701
Receivables Turnover 5.83 22.18 10.91 9.42 5.68 7.68 6.52 5.47 10.82 5.11 6.29 4.17 4.165
Payables Turnover 8.61 23.67 0.84 5.96 1.95 2.77 1.10 2.21 1.04 1.21 1.95 2.01 2.008
DSO 63 16 33 39 64 48 56 67 34 71 58 88 87.6 days
DIO 0 40 64 45 13 23 86 122 172 106 131 135 135.1 days
DPO 42 15 434 61 188 132 333 165 351 302 187 182 181.8 days
Cash Conversion Cycle 20 41 -336 22 -110 -61 -191 23 -145 -124 1 41 40.9 days
Fixed Asset Turnover snapshot only 6.631
Operating Cycle snapshot only 222.7 days
Cash Velocity snapshot only 0.382
Capital Intensity snapshot only 3.446
Growth (YoY)
Metric Trend Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
Revenue — — — — -30.2% -18.9% -26.3% -39.3% 20.1% -30.1% -31.4% -36.4% -36.38%
Net Income — — — — -4.1% -70.6% 48.6% 68.5% 83.8% 83.0% 69.3% 26.6% 26.63%
EPS — — — — -3.7% -57.4% 52.6% 70.9% 85.1% 83.8% 74.4% 38.5% 38.48%
FCF — — — — -26.9% -1.1% 19.5% 51.3% 57.4% 59.1% 59.6% 44.8% 44.84%
EBITDA — — — — -6.6% -1.0% 31.9% 56.4% 75.4% 74.8% 76.6% 49.5% 49.49%
Op. Income — — — — -6.6% -1.0% 30.6% 55.5% 74.0% 73.4% 73.8% 45.2% 45.18%
OCF Growth snapshot only 44.96%
Asset Growth snapshot only 34.19%
Equity Growth snapshot only 1.76%
Debt Growth snapshot only 6.74%
Shares Change snapshot only 19.26%
Growth Quality
Metric Trend Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
Revenue Stability — — — — — — — — 0.29 0.99 1.00 0.97 0.974
Earnings Stability — — — — — — — — 0.00 0.25 0.99 0.83 0.831
Margin Stability — — — — — — — — 0.85 0.82 0.83 0.74 0.744
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence — — — — — — — — 0.50 0.50 0.50 0.89 0.893
Earnings Smoothness — — — — — — — — — — — — —
ROE Trend — — — — — — — — 1.97 0.93 1.78 1.94 1.937
Gross Margin Trend — — — — — — — — -0.05 -0.12 -0.16 -0.25 -0.249
FCF Margin Trend — — — — — — — — 0.40 0.20 0.47 0.26 0.258
Sustainable Growth Rate — — — — — — — — — — — — —
Internal Growth Rate — — — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
OCF/Net Income -0.24 0.55 0.55 0.63 0.74 0.70 0.94 1.06 2.03 1.76 1.24 0.79 0.793
FCF/OCF 0.63 1.09 1.10 1.08 1.04 1.05 1.00 1.00 1.00 1.00 1.00 1.00 1.001
FCF/Net Income snapshot only 0.793
CapEx/Revenue 4.7% 5.9% 10.9% 9.2% 12.6% 8.2% 0.0% 0.1% 0.0% 0.0% 0.0% 0.0% 0.00%
CapEx/Depreciation snapshot only 0.000
Accruals Ratio -0.18 -0.21 -0.49 -0.51 -0.27 -0.30 -0.04 0.03 0.31 0.21 0.06 -0.08 -0.076
Sloan Accruals snapshot only 0.415
Dividends & Buybacks
Metric Trend Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
Dividend Yield — — — — — — — — — — — — 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — —
FCF Payout Ratio 0.0% — — — — — — — — — — — —
Total Payout Ratio — — — — — — — — — — — — —
Div. Increase Streak — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — —
Buyback Yield — — — — — — — — — — — — —
Net Buyback Yield — — — — — — — — — — — — —
Total Shareholder Return — — — — — — — — — — — — —
DuPont Factors
Metric Trend Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.03 1.02 1.020
Interest Burden (EBT/EBIT) 1.53 1.19 1.13 1.10 1.03 1.01 0.84 0.78 0.65 0.66 0.98 1.05 1.046
EBIT Margin -0.35 -0.99 -1.71 -1.66 -3.78 -2.47 -1.61 -1.22 -0.80 -0.92 -0.59 -1.03 -1.029
Asset Turnover 0.28 0.39 0.56 0.77 0.27 0.40 0.48 0.53 0.57 0.44 0.43 0.33 0.333
Equity Multiplier 1.27 1.24 1.88 2.12 1.59 1.55 2.36 2.50 3.73 3.10 2.81 2.04 2.039
Per Share
Metric Trend Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
EPS (Diluted TTM) $-0.51 $-1.15 $-2.10 $-2.41 $-2.41 $-1.80 $-1.00 $-0.70 $-0.36 $-0.29 $-0.26 $-0.43 $-0.43
Book Value/Share $2.74 $2.02 $1.03 $0.81 $0.38 $0.48 $0.36 $0.37 $0.28 $0.24 $0.40 $0.85 $0.85
Tangible Book/Share $2.73 $1.97 $0.97 $0.66 $0.25 $0.31 $0.22 $0.24 $0.16 $0.12 $0.31 $0.76 $0.76
Revenue/Share $0.96 $0.97 $1.09 $1.31 $0.62 $0.72 $0.74 $0.74 $0.68 $0.48 $0.42 $0.39 $0.28
FCF/Share $0.08 $-0.68 $-1.27 $-1.65 $-1.87 $-1.32 $-0.94 $-0.74 $-0.73 $-0.52 $-0.32 $-0.34 $-0.18
OCF/Share $0.12 $-0.63 $-1.15 $-1.53 $-1.79 $-1.26 $-0.94 $-0.74 $-0.73 $-0.52 $-0.32 $-0.34 $-0.18
Cash/Share $3.14 $2.13 $1.47 $1.02 $0.89 $0.82 $0.82 $0.67 $0.53 $0.50 $0.60 $1.03 $1.03
EBITDA/Share $-0.33 $-0.95 $-1.85 $-2.16 $-2.32 $-1.77 $-1.16 $-0.87 $-0.52 $-0.42 $-0.23 $-0.37 $-0.37
Debt/Share $0.08 $0.08 $0.15 $0.20 $0.24 $0.18 $0.29 $0.26 $0.28 $0.30 $0.23 $0.23 $0.23
Net Debt/Share $-3.07 $-2.04 $-1.32 $-0.82 $-0.65 $-0.65 $-0.54 $-0.41 $-0.25 $-0.20 $-0.37 $-0.79 $-0.79
Academic Models
Metric Trend Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — —
Piotroski F-Score 3 2 2 2 1 2 3 2 3 1 2 4 4
Beneish M-Score — — — — -3.54 -1.29 -2.07 -2.15 0.29 1.20 -2.70 -3.05 -3.051
Ohlson O-Score snapshot only -6.489
ROIC (Greenblatt) snapshot only -44.05%
Net-Net WC snapshot only $0.69
EVA snapshot only $-503829279.75
Credit
Metric Trend Q4'20 Q2'21 Q4'21 Q2'22 Q4'22 Q2'23 Q4'23 Q2'24 Q4'24 Q2'25 Q4'25 Q2'26 Current
Credit Rating snapshot only BBB-
Credit Score 67.75 61.00 59.65 56.70 42.95 46.70 44.30 44.30 44.30 41.45 46.55 50.00 50.000
Credit Grade snapshot only 10
Credit Trend snapshot only 5.700
Implied Spread (bps) snapshot only 350.000

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms